CARCINOMA, SQUAMOUS CELL
Clinical trials for CARCINOMA, SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for CARCINOMA, SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat anal and rectal cancers
Disease control Recruiting nowThis study is testing whether combining two drugs, lenvatinib and pembrolizumab, can help control advanced anal or rectal cancer that has spread and is no longer responding to standard chemotherapy. It will involve about 35 adults whose cancer has progressed after initial treatme…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New Triple-Threat attack on tough head and neck cancers
Disease control Recruiting nowThis early-stage study is testing a new combination of three drugs for people with advanced head and neck cancer that has returned or spread. The main goal is to find the safest and most effective dose of the new drug, Zanzalintinib, when given with two existing cancer drugs. Res…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 03, 2026 14:06 UTC
-
Blood test could warn if cancer returns after surgery
Knowledge-focused Recruiting nowThis study is testing a blood test that looks for tiny pieces of cancer DNA. It aims to see if this test can predict whether head and neck cancer comes back after a patient has surgery to remove it. Researchers will track 50 patients over time, taking blood samples before and aft…
Matched conditions: CARCINOMA, SQUAMOUS CELL
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC